Biological chemistry
2022 Activity indicators
- 9 national public competitive projects led (ISCIII, CAM, MINECO, MICINN)
- 12 competitive HR contracts
- 11 publications
- Cumulative IF: 14.54
- Q1 publications: 9 (81.8 %)
- 2 supervised doctoral theses read
- Faculty and IIS evaluator: 1 PIs
- Members of editorial committees: 2 PIs
- +13 months stay in foreign centres:
- University of Bologna (Italy)
- University of Eindhoven (The Netherlands)
- University of Berkeley (USA)
- University of California (USA)
- 1 Patent application (P202230612) through UAH-CSIC
Milestones
-
Milián A, Fernández-Rodríguez MA, Merino E, Vaquero JJ, García-García P. Metal-Free Temperature-Controlled Regiodivergent Borylative Cyclizations of Enynes: BCl3 -Promoted Skeletal Rearrangement. Angew Chem Int Ed Engl. 2022; 61(28):e202205651. doi: 10.1002/anie.202205651. PMID: 35510716.
-
de Lucio H, García-Marín J, Sánchez-Alonso P, García-Soriano JC, Toro MÁ, Vaquero JJ, Gago F, Alajarín R, Jiménez-Ruiz A. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase. Eur J Med Chem. 2022; 227:113915. doi: 10.1016/j.ejmech.2021.113915. PMID: 34695777.
-
Sans-Panadés E, Vaquero JJ, Fernández-Rodríguez MA, García-García P. Synthesis of BN-Polyarenes by a Mild Borylative Cyclization Cascade. Org Lett. 2022; 24(31):5860-5865. doi: 10.1021/acs.orglett.2c02477. PMID: 35913827.
-
Patent applied for through UAH-CSIC. Title: Peritoneal dialysis solutions containing a natural flavonoid as an osmotic agent.
Inventors: David Sucunza, Juan J. Vaquero, Manuel López Cabrera, Guadalupe Gonzalez Mateo, Valeria Kopytina Application No.: P202230612/ ES1641.1754. Country of priority: Spain -
Project RICORS 2040/RD21/0005/0005 (KIDNEY DESEASE): ISCIII-Network.
Bibliometrics
ARTICLES | ACCUM. IF | MEAN IF | ARTICLES Q1 OR Q2 | % IN Q1 OR Q2 | ARTICLES D1 | % IN D1 | |
---|---|---|---|---|---|---|---|
2018 | 1 | 4,83 | 4,83 | 1 | 100 | 1 | 100 |
2019 | 3 | 9,67 | 3,22 | 2 | 67 | 1 | 33 |
2020 | 8 | 30,81 | 3,85 | 7 | 88 | 1 | 13 |
2021 | 10 | 53,00 | 5,3 | 10 | 100 | 0 | 0 |
2022 | 11 | 74,54 | 6,78 | 11 | 100 | 4 | 36 |
33 | 172,85 | 4,80 | 31 | 91 | 7 | 36 |
* Only original articles, editorial material, guidelines and reviews.